Edwards Lifesciences ROA 2010-2024 | EW
Current and historical return on assets (ROA) values for Edwards Lifesciences (EW) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Edwards Lifesciences ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2024-09-30 | $4.16B | $12.97B | 39.45% |
| 2024-06-30 | $1.47B | $10.10B | 15.28% |
| 2024-03-31 | $1.41B | $9.74B | 15.09% |
| 2023-12-31 | $1.40B | $9.36B | 15.42% |
| 2023-09-30 | $1.43B | $9.37B | 16.21% |
| 2023-06-30 | $1.39B | $9.00B | 16.08% |
| 2023-03-31 | $1.49B | $8.65B | 17.51% |
| 2022-12-31 | $1.52B | $8.29B | 18.02% |
| 2022-09-30 | $1.46B | $8.64B | 17.17% |
| 2022-06-30 | $1.46B | $8.43B | 17.37% |
| 2022-03-31 | $1.54B | $8.42B | 18.80% |
| 2021-12-31 | $1.50B | $8.50B | 19.06% |
| 2021-09-30 | $1.48B | $8.16B | 19.53% |
| 2021-06-30 | $1.46B | $7.66B | 20.24% |
| 2021-03-31 | $0.85B | $7.21B | 12.30% |
| 2020-12-31 | $0.82B | $7.24B | 12.42% |
| 2020-09-30 | $0.79B | $6.80B | 12.32% |
| 2020-06-30 | $0.74B | $6.42B | 11.93% |
| 2020-03-31 | $1.11B | $6.08B | 18.39% |
| 2019-12-31 | $1.05B | $6.49B | 17.82% |
| 2019-09-30 | $0.77B | $5.97B | 13.86% |
| 2019-06-30 | $0.73B | $5.57B | 12.99% |
| 2019-03-31 | $0.77B | $5.47B | 13.66% |
| 2018-12-31 | $0.72B | $5.32B | 12.69% |
| 2018-09-30 | $0.71B | $5.96B | 12.33% |
| 2018-06-30 | $0.66B | $5.69B | 11.59% |
| 2018-03-31 | $0.56B | $5.83B | 10.13% |
| 2017-12-31 | $0.58B | $5.67B | 11.07% |
| 2017-09-30 | $0.75B | $5.49B | 14.96% |
| 2017-06-30 | $0.72B | $5.14B | 15.26% |
| 2017-03-31 | $0.66B | $4.78B | 14.86% |
| 2016-12-31 | $0.57B | $4.51B | 13.61% |
| 2016-09-30 | $0.55B | $4.34B | 13.55% |
| 2016-06-30 | $0.53B | $4.05B | 13.36% |
| 2016-03-31 | $0.52B | $3.85B | 13.38% |
| 2015-12-31 | $0.50B | $4.06B | 13.17% |
| 2015-09-30 | $0.46B | $3.88B | 12.78% |
| 2015-06-30 | $0.44B | $3.61B | 12.60% |
| 2015-03-31 | $0.87B | $3.49B | 25.54% |
| 2014-12-31 | $0.81B | $3.52B | 25.24% |
| 2014-09-30 | $0.78B | $3.35B | 25.82% |
| 2014-06-30 | $0.76B | $3.33B | 27.06% |
| 2014-03-31 | $0.31B | $2.65B | 11.92% |
| 2013-12-31 | $0.39B | $2.71B | 15.75% |
| 2013-09-30 | $0.40B | $2.53B | 17.17% |
| 2013-06-30 | $0.40B | $2.34B | 17.45% |
| 2013-03-31 | $0.37B | $2.30B | 16.84% |
| 2012-12-31 | $0.29B | $2.22B | 13.70% |
| 2012-09-30 | $0.27B | $2.20B | 12.84% |
| 2012-06-30 | $0.25B | $2.08B | 12.33% |
| 2012-03-31 | $0.24B | $2.00B | 11.94% |
| 2011-12-31 | $0.24B | $1.98B | 12.00% |
| 2011-09-30 | $0.24B | $1.98B | 12.44% |
| 2011-06-30 | $0.24B | $2.00B | 12.66% |
| 2011-03-31 | $0.24B | $1.93B | 13.31% |
| 2010-12-31 | $0.22B | $1.77B | 13.00% |
| 2010-09-30 | $0.20B | $1.73B | 12.27% |
| 2010-06-30 | $0.23B | $1.64B | 14.11% |
| 2010-03-31 | $0.22B | $1.60B | 13.87% |
| 2009-12-31 | $0.23B | $1.62B | 15.29% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $43.604B | $6.005B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $197.634B | 24.11 |
| Intuitive Surgical (ISRG) | United States | $186.606B | 97.56 |
| Alcon (ALC) | Switzerland | $41.521B | 27.78 |
| IQVIA Holdings (IQV) | United States | $34.761B | 19.15 |
| IDEXX Laboratories (IDXX) | United States | $33.493B | 39.44 |
| DexCom (DXCM) | United States | $29.615B | 44.60 |
| Waters (WAT) | United States | $21.413B | 31.66 |
| STERIS (STE) | Ireland | $20.170B | 23.22 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.359B | 0.00 |
| Hologic (HOLX) | United States | $16.058B | 17.34 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.192B | 13.54 |
| Sysmex ADR (SSMXY) | Japan | $11.726B | 36.77 |
| Globus Medical (GMED) | United States | $11.158B | 28.25 |
| Penumbra (PEN) | United States | $9.346B | 91.55 |
| Masimo (MASI) | United States | $9.102B | 44.04 |
| Teleflex (TFX) | United States | $8.118B | 12.95 |
| Glaukos (GKOS) | United States | $7.925B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.457B | 25.26 |
| PROCEPT BioRobotics (PRCT) | United States | $4.215B | 0.00 |
| Inari Medical (NARI) | United States | $3.185B | 0.00 |
| Veracyte (VCYT) | United States | $3.028B | 90.86 |
| Nihon Kohden (NHNKY) | Japan | $2.590B | 19.67 |
| LivaNova (LIVN) | United Kingdom | $2.579B | 14.89 |
| Tandem Diabetes Care (TNDM) | United States | $2.185B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.096B | 18.84 |
| TransMedics (TMDX) | United States | $2.031B | 64.39 |
| Integra LifeSciences Holdings (IART) | United States | $1.675B | 8.75 |
| RxSight (RXST) | United States | $1.539B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.255B | 0.00 |
| Artivion (AORT) | United States | $1.173B | 77.69 |
| Pulse Biosciences (PLSE) | United States | $1.094B | 0.00 |
| OPKO Health (OPK) | United States | $1.072B | 0.00 |
| Paragon 28 (FNA) | United States | $0.820B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.760B | 12.92 |
| Mesa Laboratories (MLAB) | United States | $0.714B | 16.83 |
| IRadimed (IRMD) | United States | $0.676B | 36.54 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.657B | 0.00 |
| AxoGen (AXGN) | United States | $0.654B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.568B | 29.92 |
| SiBone (SIBN) | United States | $0.547B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.547B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.529B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.430B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.407B | 22.01 |
| ClearPoint Neuro (CLPT) | United States | $0.404B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.357B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.349B | 0.00 |
| NeuroPace (NPCE) | United States | $0.333B | 0.00 |
| CVRx (CVRX) | United States | $0.284B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.219B | 0.00 |
| Inogen (INGN) | United States | $0.198B | 0.00 |
| Accuray (ARAY) | United States | $0.180B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.171B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.170B | 0.00 |
| Nevro (NVRO) | United States | $0.135B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.123B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.118B | 12.65 |
| Spectral Diagnostics (EDTXF) | Canada | $0.094B | 0.00 |
| LENSAR (LNSR) | United States | $0.087B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.086B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.081B | 0.00 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.071B | 0.00 |
| Hyperfine (HYPR) | United States | $0.068B | 0.00 |
| 908 Devices (MASS) | United States | $0.068B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.066B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.058B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.046B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.044B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.043B | 0.00 |
| Neuronetics (STIM) | United States | $0.039B | 0.00 |
| Envoy Medical (COCH) | United States | $0.037B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| NexGel (NXGL) | United States | $0.031B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.030B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.027B | 0.00 |
| DarioHealth (DRIO) | United States | $0.025B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.022B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.015B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.008B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.007B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |